{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T08:10:03Z","timestamp":1773303003022,"version":"3.50.1"},"reference-count":21,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JNS"],"published-print":{"date-parts":[[2013,9]]},"abstract":"\nObject<\/jats:title>\nThe direct thrombin inhibitor dabigatran has recently been approved in the US as an alternative to warfarin. The lack of guidelines, protocols, and an established specific antidote to reverse the anticoagulation effect of dabigatran potentially increases the rates of morbidity and mortality in patients with closed head injury (CHI). Confronted with this new problem, the authors reviewed their initial clinical experience.<\/jats:p><\/jats:sec>\n\nMethods<\/jats:title>\nThe authors retrospectively reviewed all cases of adult patients (age \u2265 18 years) who sustained CHI secondary to ground-level falls and who presented to the authors' provisional regional Level I trauma center between February 2011 and May 2011. The authors divided these patients into 3 groups based on anticoagulant therapy: dabigatran, warfarin, and no anticoagulants.<\/jats:p><\/jats:sec>\n\nResults<\/jats:title>\nBetween February 2011 and May 2011, CHIs from ground-level falls were sustained by 5 patients while on dabigatran, by 15 patients on warfarin, and by 25 patients who were not on anticoagulants. The treatment of the patients on dabigatran at the authors' institution had great diversity. Repeat CT scans obtained during reversal showed 4 of 5 patients with new or expanded hemorrhages in the dabigatran group, whereas the warfarin group had 3 of 15 (p = 0.03). The overall mortality rate for patients sustaining CHI on dabigatran was 2 (40%) of 5, whereas that of the warfarin group was 0 (0%) of 15 (p = 0.05).<\/jats:p><\/jats:sec>\n\nConclusions<\/jats:title>\nIt is critical for physicians involved in the care of patients with CHI on dabigatran to be aware of an elevated mortality rate if no treatment protocol or guideline is in place. The authors will soon implement a reversal management protocol for patients with CHI on dabigatran at their institution in an attempt to improve efficacy and safety in their treatment approach.<\/jats:p><\/jats:sec>","DOI":"10.3171\/2013.3.jns12503","type":"journal-article","created":{"date-parts":[[2013,5,2]],"date-time":"2013-05-02T01:30:02Z","timestamp":1367458202000},"page":"760-765","source":"Crossref","is-referenced-by-count":34,"title":["Dabigatran bleed risk with closed head injuries: are we prepared?"],"prefix":"10.3171","volume":"119","author":[{"given":"Michael W.","family":"Parra","sequence":"first","affiliation":[{"name":"Delray Medical Center\/Provisional Level I Trauma Center, Delray Beach; and"},{"name":"Nova Southeastern University College of Osteopathic Medicine, Fort Lauderdale\u2013Davie, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lloyd","family":"Zucker","sequence":"additional","affiliation":[{"name":"Delray Medical Center\/Provisional Level I Trauma Center, Delray Beach; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric S.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Delray Medical Center\/Provisional Level I Trauma Center, Delray Beach; and"},{"name":"Nova Southeastern University College of Osteopathic Medicine, Fort Lauderdale\u2013Davie, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"Gullett","sequence":"additional","affiliation":[{"name":"Delray Medical Center\/Provisional Level I Trauma Center, Delray Beach; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Avila","sequence":"additional","affiliation":[{"name":"Delray Medical Center\/Provisional Level I Trauma Center, Delray Beach; and"},{"name":"Nova Southeastern University College of Osteopathic Medicine, Fort Lauderdale\u2013Davie, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachary A.","family":"Wichner","sequence":"additional","affiliation":[{"name":"Delray Medical Center\/Provisional Level I Trauma Center, Delray Beach; and"},{"name":"Nova Southeastern University College of Osteopathic Medicine, Fort Lauderdale\u2013Davie, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Candace R.","family":"Kokaram","sequence":"additional","affiliation":[{"name":"Delray Medical Center\/Provisional Level I Trauma Center, Delray Beach; and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1754","reference":[{"key":"b1-jns12503","series-title":"National Trauma Databank Report 2006, Version 6.0","author":"American College of Surgeons"},{"key":"b2-jns12503","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009"},{"key":"b3-jns12503","series-title":"JAMA","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study","volume":"285","author":"Go","year":"2001"},{"key":"b4-jns12503","series-title":"J Clin Pathol","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1136\/jcp.2003.008904","article-title":"Warfarin reversal","volume":"57","author":"Hanley","year":"2004"},{"key":"b5-jns12503","series-title":"J Trauma","first-page":"1518","article-title":"Preinjury warfarin worsens outcome in elderly patients who fall from standing","volume":"66","author":"Howard","year":"2009"},{"key":"b6-jns12503","series-title":"J Trauma","first-page":"1131","article-title":"Rapid warfarin reversal in anticoagulated patients with traumatic intracranial hemorrhage reduces hemorrhage progression and mortality","volume":"59","author":"Ivascu","year":"2005"},{"key":"b7-jns12503","series-title":"Am Surg","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1177\/000313480807400919","article-title":"A protocol for the rapid normalization of INR in trauma patients with intracranial hemorrhage on prescribed warfarin therapy","volume":"74","author":"Kalina","year":"2008"},{"key":"b8-jns12503","series-title":"Br J Haematol","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1046\/j.1365-2141.2001.02908.x","article-title":"The management of coumarin-induced over-anticoagulation annotation","volume":"114","author":"Makris","year":"2001"},{"key":"b9-jns12503","series-title":"Am J Surg","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0002-9610(88)80548-8","article-title":"Trauma in the elderly","volume":"156","author":"Osler","year":"1988"},{"key":"b10-jns12503","series-title":"J Trauma","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1097\/00005373-199810000-00034","article-title":"Differences in mortality between elderly and younger adult trauma patients: geriatric status increases risk of delayed death","volume":"45","author":"Perdue","year":"1998"},{"key":"b11-jns12503","series-title":"Am J Surg","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.amjsurg.2008.04.003","article-title":"A promising new alternative for the rapid reversal of warfarin coagulopathy in traumatic intracranial hemorrhage","volume":"197","author":"Safaoui","year":"2009"},{"key":"b12-jns12503","series-title":"Clin Appl Thromb Hemost","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1177\/1076029609335909","article-title":"Effect of recombinant activated factor VII in critical bleeding: clinical experience of a single center","volume":"15","author":"Sartori","year":"2009"},{"key":"b13-jns12503","series-title":"Thromb Haemost","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1160\/TH06-04-0205","article-title":"A direct thrombin inhibitor studied by dynamic whole blood clot formation. Haemostatic response to ex-vivo addition of recombinant factor VIIa or activated prothrombin complex concentrate","volume":"96","author":"S\u00f8rensen","year":"2006"},{"key":"b14-jns12503","series-title":"Clin Pharmacokinet","doi-asserted-by":"publisher","first-page":"285","DOI":"10.2165\/00003088-200847050-00001","article-title":"Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate","volume":"47","author":"Stangier","year":"2008"},{"key":"b15-jns12503","series-title":"Clin Pharmacokinet","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2165\/11318170-000000000-00000","article-title":"Influence of renal impairment on the pharmacokinetics and pharmacodynamics of oral dabigatran etexilate: an open-label, parallel-group, single-centre study","volume":"49","author":"Stangier","year":"2010"},{"key":"b16-jns12503","series-title":"J Trauma","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/00005373-200208000-00004","article-title":"Traumatic brain injury in the elderly: increased mortality and worse functional outcome at discharge despite lower injury severity","volume":"53","author":"Susman","year":"2002"},{"key":"b17-jns12503","series-title":"Tenn Med","first-page":"37","article-title":"Rapid warfarin reversal with factor VIIa in an elderly trauma patient with retroperitoneal hematoma","volume":"102","author":"Testerman","year":"2009"},{"key":"b18-jns12503","series-title":"Cardiol Rev","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/CRD.0b013e3182137758","article-title":"Dabigatran etexilate: the first oral anticoagulant available in the United States since warfarin","volume":"19","author":"Tran","year":"2011"},{"issue":"Suppl 1","key":"b19-jns12503","series-title":"Haematologica","first-page":"148","article-title":"Reversibility of the anticoagulant effect of high doses of the direct thrombin inhibitor dabigatran, by recombinant Factor VIIa or activated prothrombin complex concentrate","volume":"93","author":"van Ryn","year":"2008"},{"key":"b20-jns12503","series-title":"Thromb Haemost","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1160\/TH09-11-0758","article-title":"Dabigatran etexilate\u2014a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity","volume":"103","author":"van Ryn","year":"2010"},{"key":"b21-jns12503","series-title":"Lancet","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/S0140-6736(10)61194-4","article-title":"Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial","volume":"376","author":"Wallentin","year":"2010"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/119\/3\/article-p760.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/119\/3\/article-p760.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/119\/3\/article-p760.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T17:05:37Z","timestamp":1660496737000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/119\/3\/article-p760.xml"}},"subtitle":["Clinical article"],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":21,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3171\/2013.3.jns12503","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}